205 related articles for article (PubMed ID: 10802712)
1. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice.
Zhang D; Gaussin V; Taffet GE; Belaguli NS; Yamada M; Schwartz RJ; Michael LH; Overbeek PA; Schneider MD
Nat Med; 2000 May; 6(5):556-63. PubMed ID: 10802712
[TBL] [Abstract][Full Text] [Related]
2. Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch.
Takeishi Y; Huang Q; Abe J; Glassman M; Che W; Lee JD; Kawakatsu H; Lawrence EG; Hoit BD; Berk BC; Walsh RA
J Mol Cell Cardiol; 2001 Sep; 33(9):1637-48. PubMed ID: 11549343
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy.
Sopontammarak S; Aliharoob A; Ocampo C; Arcilla RA; Gupta MP; Gupta M
Cell Biochem Biophys; 2005; 43(1):61-76. PubMed ID: 16043884
[TBL] [Abstract][Full Text] [Related]
4. TGF-β1-activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney.
Ma FY; Tesch GH; Ozols E; Xie M; Schneider MD; Nikolic-Paterson DJ
Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1410-21. PubMed ID: 21367917
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice with cardiac-specific over-expression of MLK7 have increased mortality when exposed to chronic beta-adrenergic stimulation.
Christe M; Jin N; Wang X; Gould KE; Iversen PW; Yu X; Lorenz JN; Kadambi V; Zuckerman SH; Bloem LJ
J Mol Cell Cardiol; 2004 Sep; 37(3):705-15. PubMed ID: 15350844
[TBL] [Abstract][Full Text] [Related]
6. AICAR induces cyclooxygenase-2 expression through AMP-activated protein kinase-transforming growth factor-beta-activated kinase 1-p38 mitogen-activated protein kinase signaling pathway.
Chang MY; Ho FM; Wang JS; Kang HC; Chang Y; Ye ZX; Lin WW
Biochem Pharmacol; 2010 Oct; 80(8):1210-20. PubMed ID: 20615388
[TBL] [Abstract][Full Text] [Related]
7. Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon.
Klein G; Schaefer A; Hilfiker-Kleiner D; Oppermann D; Shukla P; Quint A; Podewski E; Hilfiker A; Schröder F; Leitges M; Drexler H
Circ Res; 2005 Apr; 96(7):748-55. PubMed ID: 15761199
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-activated kinase 1 induced in spinal astrocytes contributes to mechanical hypersensitivity after nerve injury.
Katsura H; Obata K; Miyoshi K; Kondo T; Yamanaka H; Kobayashi K; Dai Y; Fukuoka T; Sakagami M; Noguchi K
Glia; 2008 May; 56(7):723-33. PubMed ID: 18293403
[TBL] [Abstract][Full Text] [Related]
9. MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium.
Kolodziejczyk SM; Wang L; Balazsi K; DeRepentigny Y; Kothary R; Megeney LA
Curr Biol; 1999 Oct; 9(20):1203-6. PubMed ID: 10531040
[TBL] [Abstract][Full Text] [Related]
10. Olmesartan ameliorates pressure overload-induced cardiac remodeling through inhibition of TAK1/p38 signaling in mice.
Wu L; Mei L; Chong L; Huang Y; Li Y; Chu M; Yang X
Life Sci; 2016 Jan; 145():121-6. PubMed ID: 26706286
[TBL] [Abstract][Full Text] [Related]
11. Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure.
Wang J; Xu N; Feng X; Hou N; Zhang J; Cheng X; Chen Y; Zhang Y; Yang X
Circ Res; 2005 Oct; 97(8):821-8. PubMed ID: 16151019
[TBL] [Abstract][Full Text] [Related]
12. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
13. The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis.
Zhang S; Weinheimer C; Courtois M; Kovacs A; Zhang CE; Cheng AM; Wang Y; Muslin AJ
J Clin Invest; 2003 Mar; 111(6):833-41. PubMed ID: 12639989
[TBL] [Abstract][Full Text] [Related]
14. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.
Niu P; Shindo T; Iwata H; Iimuro S; Takeda N; Zhang Y; Ebihara A; Suematsu Y; Kangawa K; Hirata Y; Nagai R
Circulation; 2004 Apr; 109(14):1789-94. PubMed ID: 14967720
[TBL] [Abstract][Full Text] [Related]
16. TAK1 Regulates Myocardial Response to Pathological Stress via NFAT, NFκB, and Bnip3 Pathways.
Li L; Chen Y; Li J; Yin H; Guo X; Doan J; Molkentin JD; Liu Q
Sci Rep; 2015 Nov; 5():16626. PubMed ID: 26564789
[TBL] [Abstract][Full Text] [Related]
17. Dual-Specificity Phosphatase 26 Protects Against Cardiac Hypertrophy Through TAK1.
Zhao J; Jiang X; Liu J; Ye P; Jiang L; Chen M; Xia J
J Am Heart Assoc; 2021 Feb; 10(4):e014311. PubMed ID: 33522247
[TBL] [Abstract][Full Text] [Related]
18. Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK/-JNK1/2 signaling pathway.
Li CY; Zhou Q; Yang LC; Chen YH; Hou JW; Guo K; Wang YP; Li YG
Basic Res Cardiol; 2016 Mar; 111(2):19. PubMed ID: 26891723
[TBL] [Abstract][Full Text] [Related]
19. Loss of TRADD attenuates pressure overload-induced cardiac hypertrophy through regulating TAK1/P38 MAPK signalling in mice.
Wu L; Cao Z; Ji L; Mei L; Jin Q; Zeng J; Lin J; Chu M; Li L; Yang X
Biochem Biophys Res Commun; 2017 Feb; 483(2):810-815. PubMed ID: 28013046
[TBL] [Abstract][Full Text] [Related]
20. [Transforming growth factor-β-activated kinase 1 and pathological myocardial hypertrophy].
Li Y; Chen Y; Zhang DM
Sheng Li Xue Bao; 2020 Aug; 72(4):499-505. PubMed ID: 32820312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
